½ÃÀ庸°í¼­
»óǰÄÚµå
1269656

¼¼°èÀÇ Àΰø ¸Á¸· ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç°º°, Áúȯ ÀûÀÀÁõº°(¸Á¸·»ö¼Òº¯¼ºÁõ, ³ëÀÎȲ¹Ýº¯¼º), ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(2022-2029³â)

Global Artificial Retina Market Size study & Forecast, by Product, by Disease Indication (Retinitis Pigmentosa, Age-Related Macular Degeneration, by End User and Regional Analysis, 2022-2029

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è Àΰø ¸Á¸· ½ÃÀåÀº 2021³â ¾à 271¸¸ 1,400´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø±â°£ 2022-2029³â¿¡´Â 8.20% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Àΰø ¸Á¸·Àº Á¦ÇÑµÈ ½Ã·ÂÀ» ȸº¹½ÃŰ°í ¿òÁ÷ÀÌ´Â µ¿¾È ¹®ÀÚ¸¦ ÀÐÀ» ¼öÀÖ°Ô ÇØÁÖ´Â »ý¹° ÀÇÇÐ ÀåÄ¡ÀÔ´Ï´Ù. Àΰø ¸Á¸·Àº ¸Á¸·»ö¼Òº¯¼ºÁõ°ú °°Àº ½Ã·Â Àå¾Ö¸¦ Ä¡·áÇÏ´Â µ¥ µµ¿òÀ̵˴ϴÙ. ÀÌ ÀÓÇöõÆ®´Â À̹ÌÁö¸¦ Àü±â ½ÅÈ£·Î º¯È¯ÇÏ°í ½Å°æ ¼¼Æ÷·Î Àü´ÞÇÏ°í ºûÀÇ Á¸ÀçÇÏ¿¡ À̹ÌÁö¸¦ ½Äº°ÇÔÀ¸·Î½á ¹Ì·¡¿¡ ½Ã·ÂÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ³ôÀº ÅõÀÚ, ±Þ¼ÓÇÑ ±â¼ú Áøº¸, ³ë³â Àα¸ÀÇ Áõ°¡°¡ Àΰø ¸Á¸· ½ÃÀåÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù.

2022³â 8¿ù ¹Ì±¹ ±¹¸³ ¾È°ú ¿¬±¸¼Ò(NEI)ÀÇ Åë°è¿¡ µû¸£¸é, ¸Á¸· ÀÌ¿µ¾çÁõÀº ¹Ì±¹¿¡¼­ 4000¸í Áß 1¸íÀÇ ºñÀ²·Î ¹ßº´Çϰí ÀÖÀ¸¸ç, ù Áõ»óÀº ¾ß¸ÍÁõÀÔ´Ï´Ù. µû¶ó¼­, ¸Á¸·»ö¼Òº¯¼ºÁõÀÇ À¯º´·üÀÇ Áõ°¡´Â ¿¹Ãø±â°£ µ¿¾È ½ÃÀåÀÇ À¯¸®ÇÑ ¼ºÀåÀ¸·Î À̾îÁú °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹ Áúº´°ü¸®¿¹¹æ¼¾ÅÍ(CDC)¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â 40¼¼ ÀÌ»óÀÇ ¿¬·ÉÃþ¿¡¼­ ¾à 1,200¸¸¸íÀÌ ½Ã·ÂÀå¾Ö¿¡ ½Ã´Þ¸®°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇコÄɾî ÁöÃâÀÇ Áõ°¡¿Í ¾È Áúȯ¿¡ °É¸®±â ½¬¿î ³ë³â Àα¸ÀÇ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷°ú Á¤ºÎÀÇ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ³ôÀº ÅõÀÚ, Çõ½ÅÀûÀÎ ¹ÙÀÌ¿À´Ð ºñÀü ½Ã½ºÅÛ µîÀÇ ±â¼úÀû Áøº¸°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª Àΰø ¸Á¸·ÀÇ ºñ¿ëÀÌ ³ô±â ¶§¹®¿¡ 2022-2029³â ¿¹Ãø±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÕ´Ï´Ù.

Àΰø ¸Á¸· ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, Áß³²¹Ì ¹× ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ¸Á¸· »ö¼Ò º¯¼º ȯÀÚÀÇ Áõ°¡¿Í °ß°íÇÑ ÇコÄɾî ÀÎÇÁ¶ó·Î Àΰø ¸Á¸· ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Àεµ³ª Áß±¹ µî ±¹°¡ÀÇ Á¤ºÎ Áö¿ø Áõ°¡, 1ÀÎ´ç ¼Òµæ Áõ°¡, ÀÌ Æ¯Á¤ Áö¿ª ¾È°ú º´¿ø ¹× Ŭ¸®´Ð ¼ö Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ¿¹Ãø±â°£ µ¿¾È Å« ¼ºÀå·ü·Î È®´ë ¿¹»óµË´Ï´Ù.

º» ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇÏ°í ¾ÕÀ¸·Î ¼ö³â°£ÀÇ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ »ê¾÷ÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀûÀÎ ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ÇöȲ
  • ¼¼°è¡¤ºÎ¹®º° ½ÃÀå ÃßÁ¤¡¤¿¹Ãø, 2019-2029
    • Àΰø ¸Á¸· ½ÃÀå, Áö¿ªº°, 2019-2029³â
    • Àΰø ¸Á¸· ½ÃÀå, Á¦Ç°º°, 2019-2029³â
    • Àΰø ¸Á¸· ½ÃÀå, Áúȯ ÀûÀÀÁõº°, 2019-2029³â
    • Àΰø ¸Á¸· ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2029³â
  • ÁÖ¿ä µ¿Çâ
  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ °¡Á¤

Á¦2Àå Àΰø ¸Á¸· ¼¼°è ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • Á¶»ç ´ë»ó ¹üÀ§
    • »ê¾÷ÀÇ ÁøÈ­
  • º» Á¶»çÀÇ ´ë»óÀÌ µÈ ÇØ
  • ȯÀ² º¯È¯À²

Á¦3Àå Àΰø ¸Á¸· ¼¼°è ½ÃÀå ¿ªÇÐ

  • Àΰø ¸Á¸· ½ÃÀåÀÇ ¿µÇ⠺м®(2019-2029³â)
    • ½ÃÀå ÃËÁø¿äÀÎ
      • È®´ëÇÏ´Â ÇコÄÉ¾î ºñ¿ë
      • ³ë³â Àα¸ÀÇ Áõ°¡
    • ½ÃÀåÀÇ °úÁ¦
      • Àΰø ¸Á¸·ÀÇ °íºñ¿ë
    • ½ÃÀå ±âȸ
      • ¼ºÀåÇÏ´Â ±â¼ú Áøº¸
      • ¿¬±¸°³¹ßºñ Áõ°¡

Á¦4Àå Àΰø ¸Á¸· ¼¼°è ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ Àû´ë °ü°è
  • Porter's 5 Force ¸ðµ¨¿¡ ´ëÇÑ ¹Ì·¡Àû Á¢±Ù(2019-2029³â)
  • PEST ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
  • ÅõÀÚ Ã¤¿ë ¸ðµ¨
  • ¾Ö³Î¸®½ºÆ®ÀÇ ±Ç°í¿Í °á·Ð
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«

Á¦5Àå À§Çè Æò°¡: COVID-19ÀÇ ¿µÇâ

  • COVID-19°¡ ¾÷°è¿¡ ¹ÌÄ¡´Â ÀüüÀûÀÎ ¿µÇâ¿¡ ´ëÇÑ Æò°¡
  • COVID-19 ÀÌÀü°ú COVID-19 ÀÌÈÄÀÇ ½ÃÀå ½Ã³ª¸®¿À

Á¦6Àå Àΰø ¸Á¸· ¼¼°è ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ÇöȲ
  • Àΰø ¸Á¸· ¼¼°è ½ÃÀå : Á¦Ç°º°, ½ÇÀû, ÀáÀç·Â ºÐ¼®
  • Àΰø ¸Á¸· ¼¼°è ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø 2019-2029
  • Àΰø ¸Á¸· ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
      • ¸Á¸·»ó ÀÓÇöõÆ®
      • ¸Æ¶ô¸·»ó ÀÓÇöõÆ®
      • ¸Á¸·ÇÏ ÀÓÇöõÆ®
      • ±âŸ

Á¦7Àå Àΰø ¸Á¸· ¼¼°è ½ÃÀå, Áúȯ ÀûÀÀÁõº°

  • ½ÃÀå ÇöȲ
  • Àΰø ¸Á¸· ¼¼°è ½ÃÀå : Áúȯ ÀûÀÀÁõº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • Àΰø ¸Á¸· ¼¼°è ½ÃÀå : Áúȯ ÀûÀÀÁõº° ÃßÁ¤¡¤¿¹Ãø 2019-2029
  • Àΰø ¸Á¸· ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • ¸Á¸·»ö¼Òº¯¼ºÁõ
    • ³ëÀÎȲ¹Ýº¯¼º(AMD)

Á¦8Àå Àΰø ¸Á¸· ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ÇöȲ
  • Àΰø ¸Á¸· ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • Àΰø ¸Á¸· ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº° ÃßÁ¤¡¤¿¹Ãø 2019-2029
  • Àΰø ¸Á¸· ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • ¾È°ú ¼¾ÅÍ
    • º´¿ø
    • ¿¬±¸±â°ü
    • Àü¹®º¹ÇÕº´¿ø
    • ±âŸ

Á¦9Àå Àΰø ¸Á¸· ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®

  • Àΰø ¸Á¸· ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
      • Áúȯ ÀûÀÀÁõº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
      • ÃÖÁ¾»ç¿ëÀÚº° ÃßÁ¤¡¤¿¹Ãø, 2019-2029³â
    • ij³ª´Ù
  • À¯·´ Àΰø ¸Á¸· ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç Àΰø ¸Á¸· ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« Àΰø ¸Á¸· ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • ¼¼°èÀÇ ±âŸ Áö¿ª

Á¦10Àå °æÀï Á¤º¸

  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • PIXIUM VISION
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍÀÇ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì¸¸)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • Aetna Inc.
    • Nano Retina
    • Samsara Vision, Inc
    • Ramsay Health Care UK
    • Carl Zeiss AG
    • Johnson & Johnson Vision Care, Inc
    • STAAR Surgical
    • MORCHER GmbH

10.2.10 Vivani Medical Inc.

Á¦11Àå Á¶»ç ÇÁ·Î¼¼½º

  • Á¶»ç ÇÁ·Î¼¼½º
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»çÀÇ Æ¯Â¡
  • Á¶»çÀÇ °¡Á¤
ksm 23.05.24

Global Artificial Retina Market is valued at approximately USD 2711.4 thousand in 2021 and is anticipated to grow with a healthy growth rate of more than 8.20% over the forecast period 2022-2029. An artificial retina is a biomedical device that restores limited vision and enables people to read during mobility. Artificial retina helps to treat vision problems such as retinitis pigmentosa. This implant converts the image into an electrical signal that passes to the nerve cell to identify the image in the presence of light for better eyesight vision in the future. The high investment in R&D, rapid technological advancements, and a rise in the geriatric population are expanding the Artificial Retina Market.

According to National Eye Institute (NEI) statistics in August 2022, retinal dystrophy affects 1 in every 4000 people in the U.S., with the first symptom being night blindness. Therefore, a rise in the prevalence of retinitis pigmentosa is expected to lead to lucrative growth for the market over the forecast period. For instance, according to the U.S. Centers for Disease Control and Prevention (CDC), around 12 million people in the country, falling in the age category of 40 years and above, suffer from vision impairment. Also, growing healthcare expenditure and a rise in the geriatric population that is vulnerable to eye diseases fuel the market growth. Moreover, high investment in R&D by key players and the government and technical advancements such as innovative bionic vision systems are expected to drive market growth. However, The high cost of artificial retina stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Artificial Retina Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the Artificial Retina Market due to increasing cases of retinitis pigmentosa and strong healthcare infrastructure. Asia-Pacific is expected to expand at a significant growth rate over the forecast period owing to factors such as increasing government support in countries such as India and China, increasing per capita income and the rise in the number of ophthalmic hospitals and clinics in this particular region.

Major market player included in this report are:

  • PIXIUM VISION
  • Aetna Inc.
  • Nano Retina
  • Samsara Vision, Inc.
  • Ramsay Health Care UK
  • Carl Zeiss AG
  • Johnson & Johnson Vision Care, Inc
  • STAAR Surgical
  • MORCHER GmbH
  • Vivani Medical Inc.

Recent Developments in the Market:

  • In July 2022, Nidek Co., Ltd. acquired 90% shares of Nidek Medical S.R.L. This acquisition will help the company to increase the success between Nidek Medical and Nidek.
  • In September 2021, Bionic Vision Technologies announced a strategic partnership with Cirtec Medical company, a U.S. medical technology company. With this partnership, Cirtec will assist Bionic Vision Technologies to develop and manufacture the next-generation bionic eye system.

Global Artificial Retina Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Product, Disease indication, End user, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product Type:

  • Epiretinal Implants
  • Suprachoroidal Implants
  • Subretinal Implants
  • Others

By Disease indication:

  • Retinitis Pigmentosa
  • Age-Related Macular Degeneration (AMD)
  • By End user
  • Ophthalmic Centers
  • Hospitals
  • Research Institutes
  • Multi-Specialty Hospitals
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Thousand)
    • 1.2.1. Artificial Retina Market, by Region, 2019-2029 (USD Thousand)
    • 1.2.2. Artificial Retina Market, by Product, 2019-2029 (USD Thousand)
    • 1.2.3. Artificial Retina Market, by Disease Indication, 2019-2029 (USD Thousand)
    • 1.2.4. Artificial Retina Market, by End User, 2019-2029 (USD Thousand)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Artificial Retina Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Artificial Retina Market Dynamics

  • 3.1. Artificial Retina Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing healthcare expenditure
      • 3.1.1.2. Rising geriatric population
    • 3.1.2. Market Challenges
      • 3.1.2.1. high cost of artificial retina
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing technological advancements
      • 3.1.3.2. increase in funding for research and development

Chapter 4. Global Artificial Retina Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Artificial Retina Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Artificial Retina Market by Product, Performance - Potential Analysis
  • 6.3. Global Artificial Retina Market Estimates & Forecasts by Product 2019-2029 (USD Thousand)
  • 6.4. Artificial Retina Market, Sub Segment Analysis
      • 6.4.1.1. Epiretinal Implants
      • 6.4.1.2. Suprachoroidal Implants
      • 6.4.1.3. Subretinal Implants
      • 6.4.1.4. Others

Chapter 7. Global Artificial Retina Market, by Disease Indication

  • 7.1. Market Snapshot
  • 7.2. Global Artificial Retina Market by Disease Indication, Performance - Potential Analysis
  • 7.3. Global Artificial Retina Market Estimates & Forecasts by Disease Indication 2019-2029 (USD Thousand)
  • 7.4. Artificial Retina Market, Sub Segment Analysis
    • 7.4.1. Retinitis Pigmentosa
    • 7.4.2. Age-Related Macular Degeneration (AMD)

Chapter 8. Global Artificial Retina Market, by End User

  • 8.1. Market Snapshot
  • 8.2. Global Artificial Retina Market by End User , Performance - Potential Analysis
  • 8.3. Global Artificial Retina Market Estimates & Forecasts by End User 2019-2029 (USD Thousand)
  • 8.4. Artificial Retina Market, Sub Segment Analysis
    • 8.4.1. Ophthalmic Centres
    • 8.4.2. Hospitals
    • 8.4.3. Research Institutes
    • 8.4.4. Multi-Specialty Hospitals
    • 8.4.5. others

Chapter 9. Global Artificial Retina Market, Regional Analysis

  • 9.1. Artificial Retina Market, Regional Market Snapshot
  • 9.2. North America Artificial Retina Market
    • 9.2.1. U.S. Artificial Retina Market
      • 9.2.1.1. Product breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Disease Indication breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Artificial Retina Market
  • 9.3. Europe Artificial Retina Market Snapshot
    • 9.3.1. U.K. Artificial Retina Market
    • 9.3.2. Germany Artificial Retina Market
    • 9.3.3. France Artificial Retina Market
    • 9.3.4. Spain Artificial Retina Market
    • 9.3.5. Italy Artificial Retina Market
    • 9.3.6. Rest of Europe Artificial Retina Market
  • 9.4. Asia-Pacific Artificial Retina Market Snapshot
    • 9.4.1. China Artificial Retina Market
    • 9.4.2. India Artificial Retina Market
    • 9.4.3. Japan Artificial Retina Market
    • 9.4.4. Australia Artificial Retina Market
    • 9.4.5. South Korea Artificial Retina Market
    • 9.4.6. Rest of Asia Pacific Artificial Retina Market
  • 9.5. Latin America Artificial Retina Market Snapshot
    • 9.5.1. Brazil Artificial Retina Market
    • 9.5.2. Mexico Artificial Retina Market
  • 9.6. Rest of The World Artificial Retina Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. PIXIUM VISION
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Aetna Inc.
    • 10.2.3. Nano Retina
    • 10.2.4. Samsara Vision, Inc
    • 10.2.5. Ramsay Health Care UK
    • 10.2.6. Carl Zeiss AG
    • 10.2.7. Johnson & Johnson Vision Care, Inc
    • 10.2.8. STAAR Surgical
    • 10.2.9. MORCHER GmbH

10.2.10 Vivani Medical Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦